Document Type : Original Article
Authors
1 1 Associate Professor, Health Services Management, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Student Research Committee, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Health Information Technology Research Center, Student Research Committee, Department of Medical Library and Information Sciences, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
BACKGROUND: With more than 12 million new cases of cancers and nearly 7.6 million deaths
worldwide in 2020, cancer is currently the third leading cause of mortality in the world. The costs
spent on treating patients with cancer account for a significant amount of healthcare costs. Healthcare
expenditures for cancer treatment have also increased significantly and are projected to skyrocket
further over the next decade. This study was conducted to determine medical and non‑medical direct
costs for the prevention of cancer in patients hospitalized in 10 selected educational hospitals in Iran.
MATERIALS AND METHODS: The study employed a cross‑sectional design and was conducted in
10 selected educational hospitals in Tabriz, Tehran, Isfahan, Mashhad, and Shiraz in 2020. Using
a researcher‑made questionnaire, we assessed direct medical costs and direct non-medical costs
of cancer in patients over 20 years old with kinds of breast, prostate, leukemia, lymphatic, stomach,
liver, lung, bladder, uterine, and intestine cancers who undertook oncology treatments (n = 2410).
Data were analyzed using descriptive statistics including mean and standard deviation and analytic
statistics such as Kolmogorov–Smirnov, analysis of variance, and t‑test, using SPSS 18 and P ≤0.05.
RESULT: The mean direct non-medical cost paid out of pocket per month was $99.6 ± $10.81 USD,
and the mean direct medical cost per month was $1029.4 ± $68.5 USD. The total cost paid by the
patients was $889.4 ± 69.81 USD per month.
CONCLUSION: Given the increasing number of patients with cancer, it is necessary to increase the
number of special centers for the prevention and treatment of cancers. Dissemination of information
about the costs of illnesses and their complications enables decision‑makers to make a proper
comparison between different uses of resources. Moreover, to support the patients, the health system
must implement plans to decrease out‑of‑pocket payments by patients.
Keywords
the performance of health‑care systems in upper middle
income countries: A comparative study. J Educ Health Promot.
2021 Mar 31;10:84. doi: 10.4103/jehp.jehp_290_20.
2. Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, et al.
Italian cancer figures‑‑Report 2015: The burden of rare cancers in
Italy. Epidemiol Prev 2016;40 (1 Suppl 2):1‑120.
3. Hajat C, Kishore SP. The case for a global focus on multiple chronic
conditions. BMJ Global Health 2018;3:e000874.
4. Hadian M, Jabbari A, Mazaheri E. What must Iran do for
Palliative care? A systematized review. J Educ Health Promot.
2020 Oct 30;9:276. doi: 10.4103/jehp.jehp_107_20.
5. Pisu M, Azuero A, Benz R, McNees P, Meneses K. Out‑of‑pocket
costs and burden among rural breast cancer survivors. Cancer
Med 2017;6:572‑81.
6. Jabbari A, Jafari A, Hadian M, Ghasemi M. Model‑based
Cost‑effectiveness Analysis of Atorvastatin Drugs for
Prevention of Cardiovascular Diseases in Iran. Int J Prev Med.
2020 May 19;11:57. doi: 10.4103/ijpvm.IJPVM_578_18.
7. Narang AK, Nicholas LH. Out‑of‑pocket spending and financial
burden among medicare beneficiaries with cancer. JAMA Oncol
2017;3:757‑65.
8. Bazyar M, Akbari F, Mahmoudi M. Medical and non‑medical
direct costs of cancers in patients hospitalized in Imam Khomeini
cancer institution‑2010. J Hosp 2012;11:39‑50.
9. Pisu M, Azuero A, McNees P, BurkhardtJ, BenzR, Meneses K. The
out of pocket cost of breast cancer survivors: A review. J Cancer
Survivorship 2010;4:202‑9.
10. Bahmei J, Rahimi H, Jafari A S, Habibyan M. Examination
of medical and non-medical direct costs of outpatients and
hospitalized cancer patients in Shiraz, Iran. Payesh 2015;14
:629-37.
11. Rezaei S, Akbari Sari A, Woldemichael A, Soofi M, Kazemi A,
Karami Matin B. Estimating the Economic Burden of Lung Cancer
in Iran. Asian Pac J Cancer Prev 2016;17:4729-33.
12. Eisavi M, Mazaheri E, Rezapour A, Vahedi S, Hadian M, Jafari A.
The Cost‑Effectiveness and Cost‑Utility of Statin Drug for the
Treatment of Patients with Cardiovascular Disease, A Systematic
Review. Int J Prev Med. 2021 May 15;12:39.
13. Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family
burden associated with cancer treatment in Ontario, Canada.
Support Care Cancer 2006;14:1077‑85.
14. Pashaei Asl Y, Faraz Allah Bike Nouri M, Mousayi E, Khakdel
Jelodar Z, Mohammadi M, Ghanbari Ghozhikali M, et al.
Managerial evaluation of defending natural disasters maneuver
(A case study of Tabriz maneuver in October 2013). International
Journal of Pharmacy and Technology 2015;7;9088-95.
15. Hadian M, Mozafari MR, Mazaheri E, Jabbari A. Challenges of
the Health System in Preventing Non‑Communicable Diseases;
Systematized Review. Int J Prev Med. 2021 Jun 25;12:71. doi:
10.4103/ijpvm.IJPVM_487_20.
16. Gordon LG, Ferguson M, Chambers SK, Jeff D. Fuel, beds, meals
and meds: Out-of-pocket expenses for patients with cancer in
rural Queensland. Cancer Forum 2009;33:202-8.
17. Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL,
Hayman JA. Out‑of‑pocket health‑care expenditures among older
Americans with cancer. Value Health 2004;7:186‑94.
18. Longo C, Bereza B. A comparative analysis of monthly
out‑of‑pocket costs for patients with breast cancer as compared
with other common cancers in Ontario, Canada. Curr Oncol
2011;18:e1‑8.
)